Shresta et al., 1997 - Google Patents
Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytesShresta et al., 1997
View HTML- Document ID
- 6366767035620665290
- Author
- Shresta S
- Goda P
- Wesselschmidt R
- Ley T
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
Cytotoxic lymphocytes contain granules that have the ability to induce apoptosis in susceptible target cells. The granule contents include perforin, a pore-forming molecule, and several granzymes, including A and B, which are the most abundant serine proteases in …
- 102100004383 GZMA 0 title abstract description 119
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shresta et al. | Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytes | |
| Umanoff et al. | The murine N-ras gene is not essential for growth and development. | |
| Fujimori et al. | Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G0 arrest | |
| Aslanidis et al. | Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity | |
| Schaapveld et al. | Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity | |
| US6586395B1 (en) | Apoptosis-modulating proteins | |
| US5759811A (en) | Mutant human hedgehog gene | |
| Kataoka et al. | Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location | |
| Ondr et al. | Characterization of murine cathepsin W and its role in cell-mediated cytotoxicity | |
| Scheepers et al. | Mouse GLUT8: genomic organization and regulation of expression in 3T3-L1 adipocytes by glucose | |
| WO2000053747A1 (en) | Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) | |
| US6100444A (en) | Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen | |
| CA2253433A1 (en) | Mammalian regulator of nonsense-mediated rna decay | |
| US6740793B2 (en) | Transgenic animal having a disrupted PDE7A gene and uses thereof | |
| Angelats et al. | Isolation and characterization of the mouse ubiquitin-specific protease Usp15 | |
| US20100015654A1 (en) | Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells | |
| CA2220853A1 (en) | Human lymphoid protein tyrosine phosphatases | |
| JPH09508010A (en) | Enzymes based on biological improvement | |
| EP1032595B1 (en) | Nucleic acids involved in the responder phenotype and applications thereof | |
| US20040006777A1 (en) | Human lymphoid protein tyrosine phosphatases | |
| JP2003506056A (en) | Knockout mouse of tumor suppressor gene anx7 | |
| WO2001049707A1 (en) | Gene involved in mineral deposition and uses thereof | |
| WO2002059298A9 (en) | Gab2(p97) gene and methods of use thereof | |
| WO2002063013A2 (en) | Human acid phosphatase gene | |
| Soreq | The Multileveled Regulation of the Human Cholinesterase Genes and Their Protein Products |